Abstract
[...]insulin treatment was started. According to the diagnostic criteria of FT1DM, case 1 could be definitely diagnosed. The etiology and pathogenesis of FT1DM are not well understood, but may be related to genetic susceptibility, viral infection, autoimmunity, and pregnancy. Besides our two cases of FT1DM after AP, there were several similar cases reported in Japan. [...]we suspect that AP is a pathogenic factor of FT1DM. Hirota et al[2] have reported that four of nine cases with FT1DM were diagnosed with AP and hyperinsulinemic hypoglycemia appeared 1 to 3 days after initial symptoms. [...]AP caused rapid destruction of islets, leading to hyperinsulinemia-related hypoglycemia, followed by hyperglycemia. IFN-γ can both damage β-cells and accelerate the production of CXCL10 from the remaining β-cells, further activating cell-mediated autoimmune response until β-cells are completely destroyed. [...]the destruction of β-cells in FT1DM is the result of a vicious cycle. [...]we speculate that on the basis of genetic predisposition, the immune response during AP results in immune damage and severe destruction of β-cells. [...]AP may be a pathogenic factor of FT1DM.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer